Jefferies Group's IRMD Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 7,599 shares of IRADIMED CORPORATION (IRMD) worth $731,480, representing 0.01% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in IRMD, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's IRADIMED CORPORATION (IRMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly IRADIMED CORPORATION (IRMD) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +7,599 | New Buy | 7,599 | $96.26 |
Jefferies Group's IRADIMED CORPORATION Investment FAQs
Jefferies Group first purchased IRADIMED CORPORATION (IRMD) in Q1 2026, acquiring 7,599 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held IRADIMED CORPORATION (IRMD) for 1 quarters since Q1 2026.
Jefferies Group's largest addition to IRADIMED CORPORATION (IRMD) was in Q1 2026, adding 7,599 shares worth $731,480.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 7,599 shares of IRADIMED CORPORATION (IRMD), valued at approximately $731,480.
As of the Q1 2026 filing, IRADIMED CORPORATION (IRMD) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in IRADIMED CORPORATION (IRMD) was 7,599 shares, as reported at the end of Q1 2026.